Contract 36C26125N0101

Progenics Pharmaceuticals Inc · Department Of Veterans Affairs · October 1, 2024

Firm Fixed PriceFull & Open CompetitionNAICS 325412IDIQ Task Order

Progenics Pharmaceuticals Inc was awarded a federal contract by Department Of Veterans Affairs on October 1, 2024 for $906,000 of work in pharmaceutical preparation manufacturing. Performance is in North Billerica, MA. This is a task or delivery order issued under parent IDIQ 36C26123A0025. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 19, 2025.

Obligated to date
$905.8K
$905,789
Current value
$905.8K
Modifications
2
Latest December 19, 2025

Contract details

PIID
36C26125N0101
Parent IDIQ
36C26123A0025
Award type
Bpa Call
Pricing
Firm Fixed Price
Competition
Full And Open Competition
NAICS
325412 · Pharmaceutical Preparation Manufacturing
Product / service
Drugs And Biologicals
Place of performance
North Billerica, MA
First action
October 1, 2024
Latest action
December 19, 2025

Description

RADIOACTIVE DRUG INDICATED FOR POSITRON EMISSION TOMOGRAPHY (PET) OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) POSITIVE LESIONS IN MEN WITH PROSTATE CANCER WITH SUSPECTED METASTASIS_INCREASE QUANTITIE

Modification timeline

  • December 19, 2025
    Mod P00002
    RADIOACTIVE DRUG INDICATED FOR POSITRON EMISSION TOMOGRAPHY (PET) OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) POSITIVE LESIONS IN MEN WITH PROSTATE CANCER WITH
    $36.0K
  • September 15, 2025
    Mod P00001
    RADIOACTIVE DRUG INDICATED FOR POSITRON EMISSION TOMOGRAPHY (PET) OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) POSITIVE LESIONS IN MEN WITH PROSTATE CANCER WITH
    $126.4K
  • October 1, 2024
    Base award
    RADIOACTIVE DRUG INDICATED FOR POSITRON EMISSION TOMOGRAPHY (PET) OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) POSITIVE LESIONS IN MEN WITH PROSTATE CANCER WITH
    $743.4K

Similar contracts

RecipientAgencyDateObligated
Petnet Solutions, Inc.Department Of Veterans AffairsApril 1, 2026$387.4K
Eli Lilly And CompanyDepartment Of Veterans AffairsApril 1, 2026$0
Exelan Pharmaceuticals IncDepartment Of Veterans AffairsApril 1, 2026$0
Cardinal Health 414, LlcDepartment Of Veterans AffairsApril 1, 2026$122.9K
Guardian Pharmacy Of Indianapolis Nuclear, LlcDepartment Of Veterans AffairsApril 1, 2026$0
Jubilant Draximage IncDepartment Of Veterans AffairsApril 1, 2026$0

Top contractors in NAICS 325412

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Mckesson Corporation53,729$99.76B
2Pfizer Inc4,613$28.68B
3Merck Sharp & Dohme Llc391$21.58B
4Modernatx, Inc.3$8.20B
5Sanofi Vaccines Us Inc.5,248$7.76B
6Glaxosmithkline, Llc1,418$7.22B
7Merck Sharp & Dohme Corp.349$5.33B
8Pfizer Inc.3,842$4.83B
9Eli Lilly And Company18$4.67B
10Amerisourcebergen Drug Corp497$3.23B

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract 36C26125N0101?

Contract 36C26125N0101 is a federal contract awarded to Progenics Pharmaceuticals Inc by Department Of Veterans Affairs on October 1, 2024 for $906,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.

Who won contract 36C26125N0101?

Progenics Pharmaceuticals Inc won contract 36C26125N0101 from Department Of Veterans Affairs.

How much is contract 36C26125N0101 worth?

Contract 36C26125N0101 has obligated $906,000 to date.